Loading page…
Nidan Laboratories And Healthcare Limited is listed on the NSE. Auto-imported from the exchange master list; profile pending.
Beta is measured against NIFTY 50 over three years of weekly returns — 1 moves with the index, above 1 amplifies it, below 1 damps it.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Corporate actions, results dates and filings will appear here once ingested.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Anawil Wire And Engineering LimitedANAWILANAWIL | ₹1,064 Cr | — | — | — | — | — | — | — | — | — |
| Credent Connect N Care LimitedCREDENTCREDENT | ₹696 Cr | — | — | — | — | — | — | — | — | — |
| Metalic Technoforge LimitedMETALICMETALIC | ₹426 Cr | — | — | — | — | — | — | — | — | — |
| Optimystix Entertainment India LimitedOPTIMYSTIXOPTIMYSTIX | ₹307 Cr | — | — | — | — | — | — | — | — | — |
| Pramodini Medicare LimitedPRAMODINIPRAMODINI | ₹254 Cr | ₹271 Cr | ₹62 Cr | — | — | ₹17 Cr | 27.9% | -11.3% | 39.1% | — |
| Annapurna Swadisht LimitedANNAPURNAANNAPURNA | ₹211 Cr | — | ₹520 Cr | ₹72 Cr | 13.9% | ₹32 Cr | 6.2% | — | — | — |
| Fascinate Textiles LimitedFASCINATEFASCINATE | ₹102 Cr | — | — | — | — | — | — | — | — | — |
| Propshop Events And Exhibitions LimitedPROPSHOPPROPSHOP | ₹97 Cr | — | ₹70 Cr | ₹11 Cr | 15.8% | ₹8 Cr | 11.4% | — | — | — |
| Vinod Texworld LimitedVINODVINOD | ₹82 Cr | — | — | — | — | — | — | — | — | — |
| Skytech Infinite Platform LimitedSKYTECHSKYTECH | ₹38 Cr | ₹44 Cr | — | — | — | — | — | — | — | — |
| Dhansa Labs LimitedDHANSADHANSA | — | — | ₹142 Cr | ₹11 Cr | 7.7% | ₹6 Cr | 3.9% | — | — | — |
| Divine Power Energy LimitedDPELDPEL | — | — | ₹626 Cr | ₹51 Cr | 8.1% | ₹27 Cr | 4.3% | — | — | — |
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
Standalone figures
| Ratio | Mar 2025 | Mar 2026 |
|---|---|---|
| Margins | ||
| Gross margin % | 96.9% | 96.1% |
| EBITDA margin % | 20.6% | 19% |
| EBIT margin % | 10.8% | 11.6% |
| PAT margin % | 8.1% | 5.9% |
| Working capital | ||
| Receivable days | — | — |
| Inventory days | 261 | 193 |
| Payable days | — | — |
| NWC days | — | — |
| Leverage | ||
| Current ratio | 1.1 | 1.42 |
| Debt to EBITDA | — | — |
| Debt to equity | — | — |
| Interest coverage | 2.3 | 2.5 |
| Asset turnover | 0.3 | 0.3 |
| Return ratios | ||
| Return on assets % | 2.4% | 1.8% |
| Return on capital employed % | 6.7% | 6.6% |
| Return on equity % | — | — |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
No scheme among the 32 fund houses on record reported a position in Nidan Laboratories And Healthcare Limited. Portfolios are published monthly by each AMC; coverage is still partial.
Annual reports, earnings call transcripts and presentations will appear here once ingested.
Quarterly shareholding records haven't been ingested for this company.
| ₹ Cr | Mar 2025 | Mar 2026 |
|---|---|---|
| 25 | 26 | |
| COGS | 1 | 1 |
| Gross profit | 24 | 25 |
| 19 | 20 | |
| Operating profit (EBITDA) | 5 | 5 |
| OPM % | 20.6% | 19% |
| Depreciation | 2 | 2 |
| Interest | 2 | 2 |
| 2 | 2 | |
| Profit before tax | 3 | 2 |
| Tax | 1 | 1 |
| Tax % | 28.3% | 38.5% |
| 2 | 2 | |
| PAT margin % | 8.1% | 5.9% |
| EPS (₹) | 1.4 | 1.1 |
| ₹ Cr | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | — | — |
| Reserves | — | — |
| Borrowings | — | — |
| 83 | 84 | |
| Total equity & liabilities | 83 | 84 |
| Fixed assets | 16 | 15 |
| CWIP | — | — |
| Investments | 20 | 20 |
| 47 | 49 | |
| Total assets | 83 | 84 |
| ₹ Cr | Mar 2025 | Mar 2026 |
|---|---|---|
| 2 | 2 | |
| -0 | 0 | |
| -3 | -2 | |
| Net cash flow | -1 | 0 |
| Free cash flow | 1 | 1 |
| CFO / Operating profit % | 45.1% | 34.4% |